home / stock / vnda / vnda news


VNDA News and Press, Vanda Pharmaceuticals Inc. From 06/06/24

Stock Information

Company Name: Vanda Pharmaceuticals Inc.
Stock Symbol: VNDA
Market: NASDAQ
Website: vandapharma.com

Menu

VNDA VNDA Quote VNDA Short VNDA News VNDA Articles VNDA Message Board
Get VNDA Alerts

News, Short Squeeze, Breakout and More Instantly...

VNDA - US Companies Moving the Markets, Morning edition
Thu, Jun 06, 2024 as of 10.00 am ET

A look at the top 10 most actives in the United States Nauticus Robotics Inc. (KITT) rose 29.5% to $0.1787 on volume of 92,016,620 shares Freight Technologies Inc. (FRGT) rose 92.0% to $1.2 on volume of 65,878,105 shares Aethlon Medical Inc. (AEMD) rose 68.2% to $0.7379 on volume of 48,98...

VNDA - Vanda Pharmaceuticals Confirms Receipt of Unsolicited, Non-Binding Indication of Interest from Cycle Group Holdings Ltd.

Vanda Pharmaceuticals Confirms Receipt of Unsolicited, Non-Binding Indication of Interest from Cycle Group Holdings Ltd. PR Newswire No Shareholder Action Required at This Time WASHINGTON , June 6, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. ("Van...

VNDA - Vanda Pharma surges on report of $8 takeover offer from Cycle Pharma

2024-06-06 06:59:21 ET Read the full article on Seeking Alpha For further details see: Vanda Pharma surges on report of $8 takeover offer from Cycle Pharma

VNDA - J&J transfers Ponvory FDA applications to Vanda, launch seen in Q3

2024-05-30 17:57:18 ET More on Vanda Pharmaceuticals Vanda Pharmaceuticals, Inc. (VNDA) Q1 2024 Earnings Call Transcript Vanda Pharmaceuticals: Fanapt Bipolar Win Doesn't Change Much Vanda Pharmaceuticals rejects sweetened bid from Future Pak Vanda reports po...

VNDA - Vanda Pharmaceuticals Announces Participation in the Jefferies 2024 Global Healthcare Conference

Vanda Pharmaceuticals Announces Participation in the Jefferies 2024 Global Healthcare Conference PR Newswire WASHINGTON , May 30, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in the Jeffe...

VNDA - Vanda Pharmaceuticals Announces Completion of Transfer of FDA Marketing Authorization for PONVORY®

Vanda Pharmaceuticals Announces Completion of Transfer of FDA Marketing Authorization for PONVORY® PR Newswire WASHINGTON , May 30, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that ownership of the U.S. New Drug App...

VNDA - Vanda Pharmaceuticals Announces Presentations at SLEEP 2024

Vanda Pharmaceuticals Announces Presentations at SLEEP 2024 PR Newswire WASHINGTON , May 29, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced participation at SLEEP 2024, to be held in Houston, TX from June 1 through Ju...

VNDA - Vanda Pharmaceuticals rejects sweetened bid from Future Pak

2024-05-24 16:55:06 ET More on Vanda Pharmaceuticals Vanda Pharmaceuticals, Inc. (VNDA) Q1 2024 Earnings Call Transcript Vanda Pharmaceuticals: Fanapt Bipolar Win Doesn't Change Much Vanda reports positive Phase 3 data for motion sickness drug Vanda Pharmaceu...

VNDA - Vanda Pharmaceuticals Board of Directors Determines that Revised Unsolicited Takeover Proposal is Not in the Best Interests of the Company and its Shareholders

Vanda Pharmaceuticals Board of Directors Determines that Revised Unsolicited Takeover Proposal is Not in the Best Interests of the Company and its Shareholders PR Newswire WASHINGTON , May 24, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA)...

VNDA - Vanda reports positive Phase 3 data for motion sickness drug

2024-05-15 11:26:48 ET More on Vanda Pharmaceuticals Vanda Pharmaceuticals, Inc. (VNDA) Q1 2024 Earnings Call Transcript Vanda Pharmaceuticals: Fanapt Bipolar Win Doesn't Change Much Vanda Pharmaceuticals GAAP EPS of -$0.07, revenue of $47.46M Vanda Pharmaceu...

Previous 10 Next 10